A detailed history of Lazard Asset Management LLC transactions in Cerus Corp stock. As of the latest transaction made, Lazard Asset Management LLC holds 381,751 shares of CERS stock, worth $683,334. This represents 0.0% of its overall portfolio holdings.

Number of Shares
381,751
Previous 241,125 58.32%
Holding current value
$683,334
Previous $424,000 56.6%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.7 - $2.39 $239,064 - $336,096
140,626 Added 58.32%
381,751 $664,000
Q2 2024

Aug 14, 2024

BUY
$1.62 - $2.04 $390,622 - $491,895
241,125 New
241,125 $424,000
Q2 2023

Aug 14, 2023

SELL
$1.79 - $2.9 $7,262 - $11,765
-4,057 Reduced 16.85%
20,022 $49,000
Q1 2023

May 15, 2023

BUY
$2.65 - $3.81 $26,796 - $38,526
10,112 Added 72.4%
24,079 $71,000
Q4 2022

Feb 14, 2023

SELL
$3.38 - $4.22 $497,738 - $621,437
-147,260 Reduced 91.34%
13,967 $50,000
Q3 2022

Nov 14, 2022

BUY
$3.43 - $5.83 $14,927 - $25,372
4,352 Added 2.77%
161,227 $580,000
Q2 2022

Aug 09, 2022

BUY
$4.41 - $5.69 $632,491 - $816,071
143,422 Added 1066.1%
156,875 $829,000
Q1 2022

May 13, 2022

BUY
$4.81 - $6.99 $24,069 - $34,977
5,004 Added 59.23%
13,453 $73,000
Q4 2021

Feb 09, 2022

BUY
$5.97 - $7.93 $7,271 - $9,658
1,218 Added 16.84%
8,449 $57,000
Q3 2021

Nov 15, 2021

SELL
$4.79 - $6.68 $2,725 - $3,800
-569 Reduced 7.29%
7,231 $44,000
Q1 2021

May 14, 2021

BUY
$5.68 - $7.87 $9,553 - $13,237
1,682 Added 27.49%
7,800 $46,000
Q4 2020

Feb 11, 2021

BUY
$5.25 - $8.56 $32,119 - $52,370
6,118 New
6,118 $42,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.